Novogate Medical

Company Overview

Snapshot

Founded in January 2011 by Gil Bolotin, Novogate Medical operates with 1–10 employees. The company holds a patent for its technology and is currently in the Pre-Funding stage.

Business overview

Novogate Medical develops the Wisefix system, a minimally invasive trans-apical access and closure solution. This technology is designed to address critical needs in the percutaneous valve implantation field, specifically targeting transcatheter aortic valve repair implantation and transcatheter mitral valve repair/replacement. The company operates within the Health Tech & Life Sciences sector, focusing on medical devices and medical treatment & therapeutics.

Company Intelligence Q&A

What is Novogate Medical's primary product?

Novogate Medical's primary product is Wisefix, a minimally invasive trans-apical access and closure system designed for percutaneous valve implantation procedures.

When was Novogate Medical founded?

Novogate Medical was founded in January 2011.

What is the current status of Novogate Medical?

Novogate Medical is currently non-active, having ceased operations in January 2021.

What markets does Novogate Medical's technology address?

Novogate Medical's Wisefix system addresses critical areas in the percutaneous valve implantation field, including transcatheter aortic valve repair implantation and transcatheter mitral valve repair/replacement.

What is the product stage of Wisefix?

The Wisefix product is currently in the Clinical Trial stage, as indicated by the company's product stage information.